| Metabolic gene polymorphism frequencies in control populations S Garte, L Gaspari, AK Alexandrie, C Ambrosone, H Autrup, JL Autrup, ... Cancer Epidemiology Biomarkers & Prevention 10 (12), 1239-1248, 2001 | 1132 | 2001 |
| MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers M Seike, A Goto, T Okano, ED Bowman, AJ Schetter, I Horikawa, ... Proceedings of the National Academy of Sciences 106 (29), 12085-12090, 2009 | 679 | 2009 |
| Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA T Kohno, K Shinmura, M Tosaka, M Tani, SR Kim, H Sugimura, T Nohmi, ... Oncogene 16 (25), 3219-3225, 1998 | 574 | 1998 |
| Activation of Rac1 by a Crk SH3-binding protein, DOCK180 E Kiyokawa, Y Hashimoto, S Kobayashi, H Sugimura, T Kurata, ... Genes & development 12 (21), 3331-3336, 1998 | 541 | 1998 |
| Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan T Furuta, EM El–Omar, F Xiao, N Shirai, M Takashima, H Sugimurra Gastroenterology 123 (1), 92-105, 2002 | 488 | 2002 |
| Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer Nature genetics 40 (6), 730-740, 2008 | 460 | 2008 |
| hOGG1 Ser326Cys Polymorphism and Lung Cancer Susceptibility H Sugimura, T Kohno, K Wakai, K Nagura, K Genka, H Igarashi, BJ Morris, ... Cancer Epidemiology Biomarkers & Prevention 8 (8), 669-674, 1999 | 357 | 1999 |
| Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin T Furuta, N Shirai, M Takashima, F Xiao, H Hanai, H Sugimura, K Ohashi, ... Clinical Pharmacology & Therapeutics 69 (3), 158-168, 2001 | 309 | 2001 |
| Hereditary diffuse gastric cancer: updated clinical practice guidelines VR Blair, M McLeod, F Carneiro, DG Coit, JL D'Addario, JM van Dieren, ... The Lancet Oncology 21 (8), e386-e397, 2020 | 304 | 2020 |
| Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. A Weston, JC Willey, R Modali, H Sugimura, EM McDowell, J Resau, ... Proceedings of the National Academy of Sciences 86 (13), 5099-5103, 1989 | 299 | 1989 |
| Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk S Kato, PG Shields, NE Caporaso, RN Hoover, BF Trump, H Sugimura, ... Cancer research 52 (23), 6712-6715, 1992 | 291 | 1992 |
| Evidence that DOCK180 up-regulates signals from the CrkII-p130Cas complex E Kiyokawa, Y Hashimoto, T Kurata, H Sugimura, M Matsuda Journal of Biological Chemistry 273 (38), 24479-24484, 1998 | 274 | 1998 |
| Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1 Y Otsuki, M Tanaka, S Yoshii, N Kawazoe, K Nakaya, H Sugimura Proceedings of the National Academy of Sciences 98 (8), 4385-4390, 2001 | 273 | 2001 |
| Overexpression of ERK, an EPH Family Receptor Protein Tyrosine Kinase, in Various Human Tumors E Kiyokawa, S Takai, M Tanaka, T Iwase, M Suzuki, YY Xiang, Y Naito, ... Cancer research 54 (14), 3645-3650, 1994 | 231 | 1994 |
| Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma Y Dobashi, A Sakamoto, H Sugimura, M Mernyei, M Mori, T Oyama, ... The American journal of surgical pathology 17 (4), 375-381, 1993 | 228 | 1993 |
| Enhanced Mdm2 activity inhibits pRB function via ubiquitin‐dependent degradation C Uchida, S Miwa, K Kitagawa, T Hattori, T Isobe, S Otani, T Oda, ... The EMBO journal 24 (1), 160-169, 2005 | 220 | 2005 |
| EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas K Shinmura, S Kageyama, H Tao, T Bunai, M Suzuki, T Kamo, ... Lung Cancer 61 (2), 163-169, 2008 | 216 | 2008 |
| Effects of Helicobacter pyloriinfection on gastric acid secretion and serum gastrin levels in Mongolian gerbils M Takashima, T Furuta, H Hanai, H Sugimura, E Kaneko Gut 48 (6), 765-773, 2001 | 207 | 2001 |
| Different effects of polymorphisms of tumor necrosis factor‐alpha and interleukin‐1 beta on development of peptic ulcer and gastric cancer M Sugimoto, T Furuta, N Shirai, A Nakamura, F Xiao, M Kajimura, ... Journal of gastroenterology and hepatology 22 (1), 51-59, 2007 | 200 | 2007 |
| Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas Y Dobashi, H Sugimura, A Sakamoto, M Mernyei, M Mori, T Oyama, ... Diagnostic Molecular Pathology 3 (1), 9-14, 1994 | 194 | 1994 |
